Pretreatment with ibuprofen augments circulating tumor necrosis factor-α, interleukin-6, and elastase during acute endotoxinemia

Journal of Infectious Diseases

Volumn 163, Issue 1, 1991, Pages 89-95

  Spinas, Giatgen A ^a   Bloesch, Daniel ^a   Keller, Ulrich ^a   Zimmerli, W ^a   Cammisuli, Salvatore ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ELASTASE; ENDOTOXIN; GLUCOSE; IBUPROFEN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CONTROLLED STUDY; ENDOTOXEMIA; ESCHERICHIA COLI; FEVER; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; MALE; NONHUMAN; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADULT; ANALYSIS OF VARIANCE; BLOOD PRESSURE; BODY TEMPERATURE; CELL DEGRANULATION; ENDOTOXINS; ESCHERICHIA COLI; HEART RATE; HUMANS; IBUPROFEN; INTERLEUKIN-1; INTERLEUKIN-6; LEAST-SQUARES ANALYSIS; LEUKOCYTE COUNT; MALE; NEUTROPHILS; PANCREATIC ELASTASE; REGRESSION ANALYSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0026085593     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/163.1.89     Document Type: Article

References (45)

1. Dinarello CA. Interleukin-1. Rev Infect Dis 1984;6:51-94.
2. Dinarello CA, Cannon JC, Mier JW, et al. Multiple biological activities of human recombinant interleukin-1. J Clin Invest 1986;77:1734-9.
3. Dinarello CA. Interleukin-1: amino acid sequences, multiple biological activities and comparison with tumor necrosis factor (cachectin). Year Immunol 1986;2:68-89.
4. Beutler B, Milsark IW, Cerami AC. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 1985;229:869-75.
5. Cerami A, Beutler B. The role of cachectin/TNF in endotoxin shock and cachexia. Immunol Today 1988;9:28-31.
6. Gauldie JC, Richards D, Harnish P, Lansdorp P, Baumann H. Interferon β2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci USA 1987;84:7251-5.
7. Wong GC, Clark SC. Multiple actions of interleukin-6 within a cytokine network. Immunol Today 1988;9:137-9.
8. Kishimoto T. The biology of interleukin-6. Blood 1989;74:1-10.
9. Waage A, Halstensen A, Espevik T. Association between tumor necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1987;1:355-7.
10. Girardin E, Grau GE, Dayer JM, Roux-Lombard P, the J5 Study Group, Lambert PH. Tumor necrosis factor and interleukin 1 in the serum of children with severe infectious purpura. N Engl J Med 1988;319: 397-400.
11. Waage A, Brandtzaeg P, Halstensen A, Kierluf P, Esperik T. The complex pattern of cytokines in serum from patients with meningococcal septic shock. J Exp Med 1989;169:333-8.
12. Hack CE, De-Groot ER, Felt-Bersma RJ, et al. Increased plasma levels of interleukin-6 in sepsis. Blood 1989;74:1704-10.
13. Michie HR, Manogue KR, Spriggs DR, et al. Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 1988;318:1481-6.
14. Beutler BA, Milsark IW, Cerami A. Cachectin/tumor necrosis factor: production, distribution and metabolic fate in vivo. J Immunol 1985;135:3972-7.
15. Fong Y, Moldawer LL, Marano M, et al. Endotoxemia elicits increased circulating β-2-IFN/IL-6 in man. J Immunol 1989;142:2321-4.
16. Morley J. Role of prostaglandins secreted by macrophages in the inflammatory process. Lymphokines 1981;4:377-94.
17. Chouaib S, Bertoglio JH. Prostaglandins E as modulators of the immune response. Lymphokine Res 1988;7:237-45.
18. Knudsen PJ, Dinarello CA, Strom TB. Prostaglandins posttranscriptionally inhibit monocyte expression of interleukin-1 activity by increasing intracellular cyclic adenosine monophosphate. J Immunol 1986; 137:3189-94.
19. 2 regulates macrophage-derived tumor necrosis factor gene expression. J Biol Chem 1988;263:5380-4.
20. Spengler RN, Spengler ML, Stricter RM, Remick DG, Larrick JW, Kunkel SL. Modulation of tumor necrosis factor alpha gene expression. J Immunol 1989;142:4346-50.
21. Cannon JG, van der Meer JWM, Kwiatowski D, et al. Interleukin-1 beta in human plasma: optimization of blood collection, plasma extraction, and radioimmunoassay methods. Lymphokine Res 1988;7:457-67.
22. Zimmerli W, Seligman B, Gallin JI. Exsudation primes human and guinea pig neutrophils for subsequent responsiveness to the chemotactic peptide W-formylmethionylleucylphenylalanine and increases complement component C3bi receptor expression. J Clin Invest 1986;77:925-33.
23. Metcalf JA, Gallin JI, Nauseef WM, Root RK. Laboratory manual of neutrophil function. New York: Raven Press, 1986;1-191.
24. Aarden LA, De Groot ER, Schaap OL, Lansdorp PM. Production of hybridoma growth factor by human monocytes. Eur J Immunol 1987;17:1411-6.
25. Iscove NN, Guilbert LJ, Weyman C. Complete replacement of serum in primary cultures of erythropoietin-dependent rat cell precursors (CFU-E) by albumin, transferrin, iron, unsaturated fatty acid, lecithin, and cholesterol. Exp Cell Res 1980;126:121-6.
26. Peck R, Brockhaus M, Frey JR. Cell surface tumor necrosis factor (TNF) accounts for monocyte- and lymphocyte-mediated killing of TNF-resistant target cells. Cell Immunol 1989;122:1-10.
27. 1-proteinase inhibitor. J Clin Chem Clin Biochem 1984;22:693-7.
28. Zilberstein A, Ruggieri R, Korn JH, Revel W. Structure and expression of cDNA and genes for human interferon beta-2, a distinct species inducible by growth stimulatory cytokines. EMBO J 1986;5:2529-37.
29. Van Damme J, Opdenakker G, Simpson RJ, et al. Identification of the human 26-kD protein, interferon β2 (IFN-β2), as a B-cell hybridoma/plasmacytoma growth factor induced by interleukin-1 and tumor necrosis factor. J Exp Med 1987;165:914-9.
30. Jablons DM, Mule JJ, McIntosh JK, et al. IL-6/IFN-β-2 as a circulating hormone. Induction by cytokine administration in humans. J Immunol 1989;142:1542-7.
31. Frei K, Malipiero UV, Leist TP, Zinkernagel RM, Schwab ME, Fontana A. On the cellular source and function of interleukin-6 produced in the central nervous system in viral diseases. Eur J Immunol 1989;19:689-94.
32. Jirik FR, Podor TJ, Hirano T, et al. Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells. J Immunol 1989;142:144-7.
33. Cannon JG, Tompkins RS, Gelfand JF, et al. Circulating interleukin 1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J Infect Dis 1990;161:70-84.
34. Van der Poll I, Büller HR, ten Cate H, et al. Activation of coagulation after administration of tumor necrosis factor to normal subjects. N Engl J Med 1990;322:1622-7.
35. Aggarwal BB, Eessalu TE, Hass PE. Characterization of receptors for human tumor necrosis factors and their regulation by gamma-interferon. Nature 1985;318:665-7.
36. Ruggiero V, Baglioni C. Synergistic anti-proliferative activity of interleukin 1 and tumor necrosis factor. J Immunol 1987;138:661-3.
37. Dinarello CA. Biology of interleukin 1. FASEB J 1988;2:108-15.
38. Hesse DG, Tracey KJ, Fong Y, et al. Cytokine appearance in human endotoxemia and primate bacteremia. Surg Gynecol Obstet 1988; 166:147-53.
39. Goodwin JS, Webb DR. Regulation of the immune response by prostaglandins. Clin Immunol Immunopathol 1980;15:106-22.
40. Schultz RM, Parlidis NA, Stylos WA, Chirigos MA. Regulation of macrophage tumoricidal function: a role for prostaglandin of the E series. Science 1978;202:320-1.
41. 2 and cyclic nucleotides. J Immunol 1988;41:2388-93.
42. Gordon D, Bray M, Morley J. Control of lymphokine secretion by prostaglandins. Nature 1976;262:401-2.
43. Dinarello CA, Bishai I, Rosenwasser LY, Coceani F. The influence of lipooxygenase inhibitors on the in vitro production of human leukocytic pyrogen and lymphocyte activating factor (interleukin-1). Int J Immunopharmacol 1984;6:43-50.
44. Klebanoff SJ, Vadas MA, Harlan JM, et al. Stimulation of neutrophils by tumor necrosis factor. J Immunol 1986;136:4220-5.
45. Gamble JR, Harlan JM, Klebanoff SJ, Vadas MA. Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor. Proc Natl Acad Sci USA 1985;82:8666-71.